Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,151,678
+$1,405,299 QoQ
Shares Held
44,316
-1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#873
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sowell Financial Services LLC holds $62,788,240 across 14 Drug Manufacturers - General names. ABBV ranks #2 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
57,238 | $14,536,734 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
44,316 | $11,151,678 | |
| 3 | MRK |
Merck & Co., Inc.
|
75,015 | $9,639,427 | |
| 4 | LLY |
ELI LILLY & Co
|
7,621 | $9,140,856 | |
| 5 | PFE |
Pfizer Inc
|
185,807 | $4,474,232 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
68,220 | $3,930,836 | |
| 7 | AMGN |
Amgen Inc
|
10,762 | $3,897,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,103 | $1,908,113 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,151,678 | 44,316 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $9,746,379 | 44,813 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $10,845,049 | 47,464 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $12,323,716 | 53,225 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $11,497,488 | 61,941 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $13,315,205 | 63,551 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $10,408,244 | 58,572 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $11,419,478 | 57,826 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $10,597,363 | 61,785 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,795,798 | 59,285 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $9,264,571 | 59,783 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $9,136,334 | 61,293 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,921,450 | 58,795 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,815,936 | 42,768 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,406,671 | 58,206 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,789,685 | 43,139 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $6,843,035 | 44,679 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,940,999 | 18,142 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,457,838 | 40,309 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $5,592,951 | 51,849 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $9,884,835 | 87,756 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $10,798,949 | 99,787 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $9,510,419 | 88,758 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $7,581,002 | 86,551 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,719,697 | 78,628 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,340,239 | 56,966 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||